
USFDA Grants Final ANDA Approval to Indoco Remedies for Epilepsy Drug
Previous articleIndian Drug Market Likely to Benefit as India–EU Trade Deal Signals Positive Outlook
Next article India’s Budget 2026 Charts New Health & Innovation Roadmap — Biopharma Shakti, Clinical Trials Network, NIPER Expansion and Cheaper Medicines
Next article India’s Budget 2026 Charts New Health & Innovation Roadmap — Biopharma Shakti, Clinical Trials Network, NIPER Expansion and Cheaper Medicines